Related Experiment Video
Updated: Feb 10, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Physiological aspects of nitro drug resistance in Giardia lamblia
Joachim Müller1, Andrew Hemphill1, Norbert Müller1
1Institute of Parasitology, Vetsuisse Faculty, University of Bern, Länggass-Strasse 122, CH-3012 Bern, Switzerland.
Abstract:
For over 50 years, metronidazole and other nitro compounds such as nitazoxanide have been used as a therapy of choice against giardiasis and more and more frequently, resistance formation has been observed. Model systems allowing studies on biochemical aspects of resistance formation to nitro drugs are, however, scarce since resistant strains are often unstable in culture. In order to fill this gap, we have generated a stable metronidazole- and nitazoxanide-resistant Giardia lamblia WBC6 clone, the strain C4. Previous studies on strain C4 and the corresponding wild-type strain WBC6 revealed marked differences in the transcriptomes of both strains. Here, we present a physiological comparison between trophozoites of both strains with respect to their ultrastructure, whole cell activities such as oxygen consumption and resazurin reduction assays, key enzyme activities, and several metabolic key parameters such as NAD(P)+/NAD(P)H and ADP/ATP ratios and FAD contents. We show that nitro compound-resistant C4 trophozoites exhibit lower nitroreductase activities, lower oxygen consumption and resazurin reduction rates, lower ornithine-carbamyl-transferase activity, reduced FAD and NADP(H) pool sizes and higher ADP/ATP ratios than wildtype trophozoites. The present results suggest that resistance formation against nitro compounds is correlated with metabolic adaptations resulting in a reduction of the activities of FAD-dependent oxidoreductases.
Insights
Drug resistance in Giardia lamblia is a growing concern. This study identifies metabolic adaptations, including reduced enzyme activity and altered energy levels, in resistant strains, offering insights into nitro drug resistance mechanisms.
Area of Science:
- Microbiology
- Parasitology
- Biochemistry
Background:
- Metronidazole and nitazoxanide are primary treatments for giardiasis.
- Increasing resistance to these nitro compounds necessitates new research models.
- Stable resistant strains are crucial for studying resistance mechanisms.
Purpose of the Study:
- To generate and characterize a stable Giardia lamblia clone resistant to metronidazole and nitazoxanide.
- To conduct a physiological comparison between resistant (C4) and wild-type (WBC6) Giardia lamblia strains.
- To investigate the biochemical and metabolic basis of nitro compound resistance.
Main Methods:
- Generation of a stable resistant Giardia lamblia clone (C4).
- Comparative analysis of trophozoite ultrastructure.
- Measurement of whole cell activities (oxygen consumption, resazurin reduction).
- Assay of key enzyme activities (e.g., ornithine carbamoyltransferase).
- Quantification of metabolic parameters (NAD(P)+/NAD(P)H, ADP/ATP ratios, FAD content).
Main Results:
- Resistant C4 strain showed lower nitroreductase, oxygen consumption, and resazurin reduction activities.
- Ornithine carbamoyltransferase activity was reduced in the resistant strain.
- Reduced FAD and NADP(H) pool sizes and higher ADP/ATP ratios were observed in C4 trophozoites.
- Nitroreductase activities were significantly lower in resistant strains.
Conclusions:
- Nitro compound resistance in Giardia lamblia is linked to significant metabolic adaptations.
- These adaptations involve a reduction in the activity of FAD-dependent oxidoreductases.
- The findings provide a model for studying nitro drug resistance in parasitic protozoa.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Quantitative Aspects of Drug-Receptor Interaction
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Resistivity
Resistance
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...